Dr Belamy Cheung
BMed, MSc (Sun Yat-Sen University of Medical Science, Guangzhou), PhD (UNSW)
Dr Belamy Cheung is Principal Scientist in the Embryonal Cancer Therapy and Prevention Grouyp at Children's Cancer Institute and a conjoint Senior Lecturer in the UNSW Faculty of Medicine. She was the first to show that the retinoic acid receptor beta acts as a tumour suppressor gene in neuroblastoma and predicts a more favourable outcome for neuroblastoma patients.
Her current research is focusing on drug discovery leading to the identification of small molecule inhibitors of oncogene targets. She plays a key role in directing research in the Embryonal Cancer Therapy and Prevention and driving research in MYC oncogenesis, the mechanisms of embryonal cancer initiation, and histone deacetylase inhibitor combination therapy in cancer.
Dr Cheung has been awarded research grants and fellowships from external and internal funding bodies including Cancer Institute NSW, Cure Cancer Australia and UNSW. Over the past decade, Belamy has authored a number of peer-reviewed publications in well-known scientific journals including Nature Reviews Cancer, Science Translational Medicine, Oncogene and Journal of Pathology.